|
PCCB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.198200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.696200E-01 |
| Normal-vs-Stage2 |
1.221190E-03 |
| Normal-vs-Stage3 |
5.392300E-02 |
| Normal-vs-Stage4 |
8.184500E-02 |
| Stage1-vs-Stage2 |
5.769100E-04 |
| Stage1-vs-Stage3 |
1.343840E-01 |
| Stage1-vs-Stage4 |
1.918210E-01 |
| Stage2-vs-Stage3 |
8.38579999999922E-05 |
| Stage2-vs-Stage4 |
1.042080E-04 |
| Stage3-vs-Stage4 |
7.501400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.858980E-01 |
| Normal-vs-AfricanAmerican |
2.054800E-01 |
| Normal-vs-Asian |
4.755400E-01 |
| Caucasian-vs-AfricanAmerican |
7.112200E-01 |
| Caucasian-vs-Asian |
9.814600E-01 |
| AfricanAmerican-vs-Asian |
8.151000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.942600E-01 |
| Normal-vs-Female |
9.720200E-01 |
| Male-vs-Female |
4.528600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.064000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.392000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.265150E-01 |
| Normal-vs-Age(81-100Yrs) |
6.378800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.244200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.849700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.208400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.754300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.654400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.593000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.636200E-02 |
| Classical-VS-Follicular |
6.46659999992139E-08 |
| Classical-VS-Other |
6.395600E-01 |
| Classical-VS-Normal |
1.778070E-02 |
| Tall-VS-Follicular |
1.51529999659061E-09 |
| Tall-VS-Other |
8.488800E-01 |
| Tall-VS-Normal |
3.846800E-04 |
| Follicular-VS-Other |
3.043100E-03 |
| Follicular-VS-Normal |
4.23280000000359E-05 |
| Other-VS-Normal |
9.704500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.251200E-01 |
| Normal-vs-N1 |
1.227330E-04 |
| N0-vs-N1 |
1.48799999999394E-06 |
|
|
